Oocyte cryopreservation in a patient with sickle cell disease prior to hematopoietic stem cell transplantation: First report

Journal of Assisted Reproduction and Genetics

Volumn 29, Issue 3, 2012, Pages 265-269

  Dovey, Serena ^a   Krishnamurti, Lakshmanan ^b   Sanfilippo, Joseph ^a   Gunawardena, Sriya ^b   McLendon, Patricia ^b   Campbell, Mary ^b   Alway, Sandra ^a   Efymow, Brenda ^c   Gracia, Clarisa ^c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Controlled ovarian stimulation; Fertility preservation; Hematopoietic stem cell transplantation; Oocyte cryopreservation; Sickle cell disease

Indexed keywords

ENOXAPARIN; ESTRADIOL; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN; RECOMBINANT LUTEINIZING HORMONE;

ACUTE CHEST SYNDROME; ADULT; ARTICLE; CASE REPORT; CHOLECYSTECTOMY; CONSULTATION; CRYOPRESERVATION; DISEASE SEVERITY; ENDOCRINOLOGIST; ESTRADIOL BLOOD LEVEL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPOGONADISM; IN VITRO OOCYTE MATURATION; INFORMED CONSENT; LUTEINIZING HORMONE BLOOD LEVEL; MEDICAL HISTORY; MENSTRUAL CYCLE; OOCYTE; OOCYTE RETRIEVAL; OVARIAN RESERVE; OVARY HYPERSTIMULATION; OVARY INSUFFICIENCY; OVULATION INDUCTION; PREGNANCY; PRIORITY JOURNAL; REHYDRATION; REPRODUCTIVE PROCEDURE; SICKLE CELL ANEMIA; SPLENECTOMY; THROMBOEMBOLISM; THROMBOSIS; TISSUE PRESERVATION; TRANSVAGINAL ECHOGRAPHY; WHOLE BODY RADIATION; METHODOLOGY; PATHOPHYSIOLOGY;

ADULT; ANEMIA, SICKLE CELL; CRYOPRESERVATION; FEMALE; FERTILITY PRESERVATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; OOCYTE RETRIEVAL; OOCYTES; OVULATION INDUCTION; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84863184495     PISSN: 10580468     EISSN: 15737330     Source Type: Journal    
DOI: 10.1007/s10815-011-9698-2     Document Type: Article

References (39)

1. Abboud RM. Hematopoietic stem-cell transplantation for adults with sickle cell disease. N Engl J Med. 2009;361(24):2380-81.
2. Ohene-Frempong K, Weiner SJ, Sleeper LA, Miller ST, Embury S, Moohr JW, Wethers DL, Pegelow CH, Gill FM. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998;91(1):288-94. (Pubitemid 28018756)
3. Minter KR, Gladwin MT. Pulmonary complications of sickle cell anemia. A need for increased recognition, treatment, and research. Am J Respir Crit Care Med. 2001;164(11):2016-19.
4. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP. Mortality in sickle cell disease: life expectancy and risk factors for early death. N Engl J Med. 1994;330(23):1639-44.
5. Walters MC, Hardy K, Edwards S, Adamkiewicz T, Barkovich J, Bernaudin F, Buchanan GR, Bunin N, Dickerhoff R, Giller R, et al. Pulmonary, gonadal and central nervous system status after bone marrow transplantation for sickle cell disease. Biol Blood Marrow Transplant. 2010;16:263-72.
6. Sklar C. Maintenance of ovarian function and risk of premature menopause related to cancer treatment. J Natl Cancer Inst Monogr. 2005:25-7.
7. Schimmer AD, Quatermain M, Imrie K, Ali V, McCRae J, Stewart AK, Crump M, Derzko C, Keating A. Ovarian function after autologous bone marrow transplantation. J Clin Oncol. 1998;16:2359-63. (Pubitemid 28309028)
8. Thibaud E, Rodriguez-Macias K, Trivin C, Esperou H, Michon J, Brauner R. Ovarian function after bone marrow transplantation during childhood. Bone Marrow Transplant. 1998;21:287-90. (Pubitemid 28052232)
9. Sarafoglou K, Boulad F, Gillio A, Sklar C. Gonadal function after bone marrow transplantation for acute leukemia during childhood. J Pediatr. 1997;130:210-6. (Pubitemid 27495155)
10. Matsumoto M, Shinohara O, Ishiguro H, et al. Ovarian function after bone marrow transplantation performed before menarche. Arch Dis Child. 1999;80:452-4. (Pubitemid 29220182)
11. Sanders JE, Hawley J, Levy W, et al. Pregnancies following highdose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood. 1996;87:3045-52.
12. Mayer EI, Dopfer RE, Klingebiel T, Scheel-Walter H, Ranke MB, Neithammer D. Longitudinal gonadal function after bone marrow transplantation for acute lymphoblastic leukemia during childhood. Pediatr Translant. 1999;3(1):38-44. (Pubitemid 29234291)
13. Vlachapapodopoulou E,Kitra V, Peristeri J,Goussetis E, Karachaliou F, Petropoulos D, Fotinou A, Michalacos S, Graphakos S. Gonadal function of young patients with beta-thalassemia following bone marrow transplantation. J Pediatr Endocrinol Metab. 2005;18 (5):477-83. (Pubitemid 40645582)
14. Noyes N, Porcu E, Borini A. Over 900 oocyte cryopreservation babies born with no apparent increase in congenital anomalies. Reprod Biomed Online. 2009;18:769-76.
15. Ataga KI, Orringer EP. Hypercoagulability in sickle cell disease: a curious paradox. Am J Med. 2003;115:721-28. (Pubitemid 38032666)
16. Charneski L, Congdon HB. Effects of antiplatelet and anticoagulant medications on the vasoocclusive and thrombotic complications of sickle cell disease: a review of the literature. Am J Health Syst Pharm. 2010;67:895-900.
17. Smith GD, Serafina PC, Fioravanti J, Yadid I, Coslovsky M, Hassun P, Alegretti JR, Motta EL. Prospective randomized comparison of human oocytes cryopreservation with slow-rate freezing or vitrification. Fertil Steril. 2010;94(6):2088-95.
18. Shalet SM, Didi M, Ogilvy-Stuart AL, Schulga J, Donaldson MD. Growth and endocrine function after bone marrow transplantation. Clin Endocrinol (Oxf). 1995;42:333-9.
19. Schubert MA, Sullivan KM, Schubert MM, et al. Gynecological abnormalities following allogeneic bone marrow transplantation. Bone Marrow Transplant. 1990;5:425-30. (Pubitemid 20344126)
20. Lee SJ, Schover LR, Partridge AH, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006;24:2917-31. (Pubitemid 46655598)
21. Cobo A, Domingo J, Perez S, Crespo J, Remohi J, Pellicer A. Vitrification: an effective new approach to oocyte banking and preserving fertility in cancer patients. Clin Transl Oncol. 2008;10:268-73.
22. Oktay K, Cil AP, Bang H. Efficiency of oocyte cryopreservation: a meta-analysis. Fertil Steril. 2006;86:70-80. (Pubitemid 43962981)
23. Practice Committee of the American Society of Reproductive Medicine. Ovarian tissue and oocyte cryopreservation. Fertil Steril. 2008;90:S241-246.
24. . Donnez J, Silbers S, Andersen CY, Demeestere I, Piver P, Meirow D, Pellicer A, Dolmans MM. Children born after autotransplantation of cryopreserved ovarian tissue: a review of 13 live births. Ann Intern Med. 2011;43:437-50.
25. Roux C, Amiot C, Agnani G, Aubard Y, Rohrlich PS, Piver P. Live birth after ovarian tissue autograft in a patient with sickle cell disease treated by allogeneic bone marrow transplantation. Fertil Steril. 2010;93(7):2413.e15-9.
26. Kirkpatrick MB, Haynes J. Sickle cell disease and the pulmonary circulation. Semin Respir Crit Care Med. 1994;15:473-81. (Pubitemid 24372238)
27. Ataga KI. Hypercoagulability and thrombotic complications in hemolytic anemia. Hematologica. 2009;94(11):1481-84.
28. Villers MS, Jamison MG, DeCastro LM, James AH. Morbidity associated with sickle cell disease in pregnancy. Am J Obste Gynecol. 2008;199:125.e1-5.
29. American College of Obstetricians and Gynecologists Practice Bulletin. Use of hormonal contraception in women with coexisting medical conditions. ACOG Practice Bulletin No 73; 2006:1-20.
30. Chan WS, Dixon ME. The ART of thromboembolism: a review of assisted reproductive technology and thromboembolic complications. Thromb Res. 2008;121:713-26. (Pubitemid 351491278)
31. Stewart JA, Hamilton PJ, Murdoch AP. Thromboembolic disease associated with ovarian stimulation and assisted conception techniques. Hum Reprod. 1997;12(10):2167-73. (Pubitemid 27494024)
32. Vloeberghs V, Peeraer K, Pexsters A, D'Hooghe T. Ovarian hyperstimulation syndrome and complications of ART. Best Pract Res Clin Obstet Gynaecol. 2009;23:691-709.
33. Kol S, Itskovitz-Eldor J. Gonadotropin-releasing hormone agonist trigger: the way to eliminate ovarian hyperstimulation syndrome-a 20 year experience. Semin Reprod Med. 2010;28(6):500-5.
34. Engmann L, DiLuigi A, Schmidt D, Nulsen J, Maier D, Benadiva C. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective, randomized controlled study. Fertil Steril. 2008;89 (1):84-91.
35. Stuart MJ, Nagel R. Sickle-cell disease. Lancet. 2004;364:1343-60. (Pubitemid 39335827)
36. National Institute of Health, National Heart, Lung and Blood Institute, Division of Blood Diseases and Resources. The management of sickle cell disease. NIH Publication No 02-2117, 4th edition, 2002: 1-188
37. Ballas SK. Sickle cell anaemia: progress in pathogenesis and treatment. Drugs. 2002;62(8):1143-72. (Pubitemid 34587570)
38. Benjamin LJ, Dampier CD, Jacox AK et al. Guidelines for the management of acute and chronic pain in sickle cell disease. APS clinical practice guideline series no 1. Glenview, IL, 1999.
39. Morrissey LK, O'Brian Shea J, Kalish LA, Weiner DL, Branowicki P, HeeneyMW. Clinical practice guideline improves the treatment of sickle cell disease vasoocclusive pain. Pediatr Blood Cancer. 2009;52:369-72.